Feds expand probe into electric unicycles and sneaky components
Published Date: 9/18/2026
Notice
Summary
The U.S. International Trade Commission is moving forward with a case about gyro-stabilized electric unicycles, adding a new company, LeaperKim Coyote, to the investigation. This affects companies importing or selling these unicycles in the U.S., with potential impacts on sales and patents. The case started in March 2026 and is now expanding, signaling serious attention to patent rights and market control.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
LeaperKim Coyote Added as Respondent
On September 15, 2026 the U.S. International Trade Commission voted not to review an ALJ order and added Guangzhou Coyote Intelligent Equipment Co., Ltd. d/b/a LeaperKim ("LeaperKim Coyote") as a respondent in Investigation No. 337-TA-1488. The ALJ issued the initial determination granting the amendment on August 18, 2026 after a motion filed August 7, 2026.
Section 337 Patent Infringement Allegations
The investigation, instituted March 5, 2026, alleges violations of section 337 (19 U.S.C. 1337) for importation into the United States, sale for importation, and sale within the United States of certain gyro-stabilized electric unicycles and components by reason of infringement of U.S. Patent No. 8,807,250 and U.S. Patent No. D729,698. The complaint also alleges that a U.S. industry exists or is in the process of being established.
Inmotion Terminated After Settlement
Respondent Inmotion Technologies Co., Ltd. d/b/a Inmotion was terminated from this investigation based on a settlement agreement (Order No. 11, May 21, 2026), as noted in the Commission notice dated June 18, 2026. That termination removes Inmotion from Investigation No. 337-TA-1488.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-19175, Certain Electronic Devices With Certain Audio Technologies; Notice of Institution of Investigation
BoomCloud 360 Inc. has asked the U.S. International Trade Commission to investigate certain electronic devices with special audio tech for patent infringement. If the claims are true, some products might be blocked from being sold or imported into the U.S., which could shake up the market soon. This investigation started on September 15, 2026, and could lead to big changes for companies selling these devices.
2026-19096, Certain Wireless Communication Devices and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Terminating the Investigation as to Certain Respondents; Termination of the Investigation
The U.S. International Trade Commission has ended its investigation into certain wireless devices after some companies settled and were dropped from the case. This means no more legal action for those companies, and the investigation is officially closed. If you’re involved with these wireless products, the matter is settled with no new fees or penalties coming your way.
2026-19045, Certain Balloon Dilation Devices, Systems, and Components Thereof; Notice of a Commission Determination To Review in Part a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions on the Issues Under Review and Remedy, the Public Interest, and Bonding; Extension of Target Date
The U.S. International Trade Commission is taking a second look at a decision about certain balloon dilation devices that might have broken trade rules. They’re asking for input on how to fix the issue, how it affects the public, and money matters. The deadline for wrapping this up is now extended to November 13, 2026, so companies involved should stay tuned and get ready to share their views.
2026-18644, Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint from Vicor Corporation about some power delivery and computing systems being imported and sold in the U.S. They want the public to share their thoughts on how this might affect everyone. This could lead to changes in what products are allowed, so companies involved and consumers should pay attention soon.
2026-18586, Citric Acid and Certain Citrate Salts From Canada and India; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations
The U.S. is checking if imports of citric acid and certain citrate salts from Canada and India are hurting American businesses. This investigation will decide if extra taxes (duties) should be added to these imports to keep things fair. The final decision is scheduled soon, and it could impact prices and trade starting August 26, 2026.
2026-18379, Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint from trinamiX about some mobile devices and parts, pointing fingers at Apple. They’re asking for rules to stop these products from being sold in the U.S. while the case is reviewed. If you’re interested, you can share your thoughts soon—this could shake up the tech world and affect sales during the next two months.
Previous / Next Documents
Previous: 2026-19164, Environmental Impact Statements; Notice of Availability
The EPA just shared new Environmental Impact Statements (EIS) for projects like dam upgrades and transit expansions that affect communities in California, Washington, and Utah. These reports help everyone understand how projects might impact the environment, and you’ve got until early November or October to share your thoughts. No big money changes announced, but these updates keep important projects moving safely and smartly.
Next: 2026-19166, Biosimilar User Fee Act III Future Needs in the Development of Interchangeable Products Post-Workshop; Draft Strategy Document
The FDA just shared a draft plan to help make interchangeable biosimilar drugs easier to develop and approve. This affects drug makers and patients who want more affordable medicine options. The FDA wants your feedback by November 17, 2026, before finalizing the plan, which supports innovation and smoother drug approvals through 2027.